Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Vuzix Stock Is An Emerging AR Smart Glass Play

Published 12/10/2020, 06:15 AM
Updated 09/29/2021, 03:25 AM

Augmented reality smart glass maker Vuzix (NASDAQ:VUZI) stock has been a pandemic benefactor outperforming the benchmark S&P 500 index. It’s said that the COVID-19 pandemic has accelerated the migration and adoption of digital technologies and ecommerce by a decade within a year’s time. Remote, streaming, contactless and convenience are the core themes in the age of COVID. Just like the initial 3COM Palm Pilots and Apple (NASDAQ:AAPL) Newton tablets initially bombed, these precursors paved the way for mobile tablets to become a mainstream household consumer and commercial product now. The same may apply to augmented reality and smart glasses. The pandemic has given a resurgence to the utility of the smart glass technology, referred to as “optical see-through systems”, notably in the medical and commercial segments. The adoption is here to stay and likely grow moving forward in the “new normal”. Prudent investors can wait for opportunistic pullback price levels to gain exposure in this emerging trend.

Q3 FY 2020 Earnings Release

On Nov. 9, 2020, Vuzix (NASDAQ:VUZI) its Q3 2020 results for the quarter ending September 2020. The Company reported an GAAP earnings-per-share (EPS) loss of (-$0.13) in-line with consensus analyst estimates. Revenues rose 156% year-over-year (YoY) to $2.78 million and up 15% sequentially. Follow-on orders continued to accelerate from Q2 primarily driven by existing and new customers in healthcare. Telemedicine, telehealth patient care, training and surgery continue to be an “important new business segment for Vuzix.”, according to CEO Paul Travers. Margins improved to 47% compared to 36% YoY. The Company ended the quarter with $24.9 million in cash and cash equivalents and $31 million in overall working capital.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Conference Call Takeaways

Vuzix CEO, Paul Travers, stated:

“The COVID-19 pandemic has become a catalyst for much broader acceptance of enterprise smart glasses, resulting in shorter evaluation periods and increase customer adoptions.”

He noted that along with healthcare, field service and manufacturing sectors are key growth drivers heading into strong record October sales. The OEM and Engineering Services business is actively engaged with five active programs collectively representing $700,000 in commitments. October has kicked off the fourth quarter with the highest single monthly sales in the Company’s history. Travers noted:

“We’re seeing replenishment orders from resellers, follow-on orders from direct customers and a continued stream of inbound sales from new customers, as our core Smart Glass business continues to accelerate across the globe.”

“We are just getting started with broader smart glasses adoption by enterprise users. Why send the person when you can send a pair of Vuzix Smart glasses? Deploying Vuzix Smart Glasses in enterprise is a safer, cheaper, faster and in many respects a better way of doing business.”

Further noting that ,”the pandemic has forced the point.”

Enterprise Adoption of Vuzix Optical See-Through Systems

The Vuzix M400 accounted for the majority of sales. The M400 captures and streams industry-leading 4K at 30 frames-per-second HD streaming video with image stabilized and autofocusing camera on OLED display especially useful for field service workers. The voice controls built into the base operating system makes it a complete hands-free device. The glasses integrate with video conferencing platforms including Zoom Video (NASDAQ:ZM), Skype, and Cisco WebEx (NASDAQ:CSCO). The M4000 provides a 5000-nit display providing double the field view of the M400. The Blade upgraded version includes built-in stereo audio features. The Company noted th “growing acceleration in adoption driven by business continuity plans and the urgent need to deliver remote expertise without having personnel on site.”

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Some of the notable customer wins include Clorox (NYSE:CLX), Pixee Medical and Medtronic (NYSE:MDT). Smart glasses being used from virtual ICU monitoring by doctors doing rounds, to knee replacement operation surgeries training, clinical trials, remote student learning to manufacturing operations support, and auditing. The Company continues to work with Verizon (NYSE:VZ) as a distributor for its EMS solutions bundling of hardware and 5G services focused on bringing “situational awareness technology” to public safety and first responders. Prudent investors that believe in the growth prospect from enterprise adoption of smart glasses can watch for opportunistic pullback levels in shares of Vuzix.

VUZIX Corp Stock Chart

VUZI Opportunistic Pullback Levels

Using the rifle charts on the monthly and weekly time frames provides a broader view of the landscape for VUZI stock. The monthly rifle chart formed a mini pup breakout triggered above the monthly market structure low (MSL)triggered above $1.73. Shares peaked off the $5.27 Fibonacci (fib) level.

The monthly 5-period moving average (MA) support at $4.16 needs to hold long enough for the weekly stochastic to cross up to trigger a monthly stochastic mini pup. The weekly rifle chart has pulled back with a stalled downtrend as the weekly stochastic decides to either crossover back up or form a mini inverse pup drop towards the 20-band.

Since shares are trading over double the pre-COVID highs, prudent investors can wait for opportunistic pullback levels at the $3.89 fib, $3.41 fib, $3.08 fib and the $2.74 fib. Again, it is worth noting that the cheaper the entry, the better value can be derived. While the Company is finally hitting on all cylinders, much of the expectations are priced into the stock and thus deeper pullbacks are the best defense. Upside trajectories range from the $5.27 fib to the $7.80 fib.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Original Post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.